References
- G Powis. (1991). Trends Pharmacol Sci 12:188.
- P Traxler, and P Furet. (1999). Pharmacol Ther 82:195.
- WG Cance, and ET Liu. (1995). Breast Cancer Res Treat 35:105.
- EB Yang, DF Wang, LY Cheng, and P Mack. (1997). Cancer J 10:319.
- EB Yang, YJ Guo, K Zhang, YZ Chen, and P Mack. (2001). Biochim Biophys Acta 1550:144.
- C Szantai-kis, I Kovesdi, D Eros, P Banhegyi, A Ulrich, G Keri, and L Ofri. (2006). Curr Med Chem 13 (3):277.
- A Kurup, R Gorg, and C Hansch. (2001). Chem Rev 101:2573.
- A Vema, SK Panigrahi, G Rambabu, B Gopalakrishnan, JA Sarma, and GR Desiraju. (2003). Bioorg Med Chem 11:4643.
- G Chen, X Luo, W Zhu, C Luo, H Liu, CM Puah, K Chen, and H Jiang. (2004). Bioorg Med Chem 12:2409.
- BW Clare. (1998). J Med Chem 41:3845–3856.
- CT Supuran, and BW Clare. (2004). J Enz Inhib Med Chem 19:237–248.
- BW Clare. (2004). THEOCHEM 712:143–148.
- BW Clare. (2006). THEOCHEM 763:207–215.
- P Mariano, T Ivanka, and P Iliza. (2006). Int J Quant Chem 106 (6):1432.
- BW Clare. 2005. nodangle.zip. http://www.chem.biomedchem.uwa.edu.au/staff/homepages/BrianClare.
- BW Clare. 2005. martha.zip. http://www.chem.biomedchem.uwa.edu.au/staff/homepages/BrianClare.
- BW Clare, and CT Supuran. (2005). Bioorg Med Chem 13:2197–2211.
- Hypercube Hyperchem 1115 NW 4th Street, Gainesville, Florida 32601-4256 U.S.A..
- JJP Stewart. (1990). Q.C.P.E. Bull 10:86.
- MS Tute. In: NJ Harter, and AB Simmord, editors. History and objectives of Quantitative Drug Design in Advances in Drug Research, Vol. 6, London: Academic Press; (1971). p. 1.
- C Hansch, editors. Comprehensive Drug Design. New York: Pergamon Press; (1990).
- JG Topliss, and RJ Costello. (1972). J Med Chem 15:1066–1068.